Delighted to see this piece of work finally come out. Done with colleagues at the Northern Institute for Cancer Research over several years, my role was to do initial identification of possible therapeutic agents on AML cell lines. Still remember when I showed my PI the promising results with palbociclib for the first time! Many congratulations to my colleagues who took that initial piece of information and built this incredible, comprehensive piece of research that will hopefully lead to new and less toxic treatment approaches for hard-to-treat AML.
The paper is open-access here: